Evercore ISI Starts Coverage on UnitedHealth With Bullish View
Evercore ISI initiates UnitedHealth with an Outperform rating and a $400 price target, citing a successful turnaround and long-term growth potential.
NOTRELOAD AI
Staar Surgical Shareholders Block $1.6B Alcon Acquisition Deal
Staar Surgical shareholders reject Alcon's $1.6 billion takeover bid after activist investor campaign. Company to remain independent on Nasdaq.
FDA Grants Breakthrough Status to Vision-Saving Drug for Optic Neuritis
Oculis (OCS) receives FDA Breakthrough Therapy Designation for Privosegtor, a promising treatment that could become the first neuroprotective therapy for optic neuritis and related eye conditions.
Northland Backs Nebius as a Top Pick for 2026
Northland names Nebius a top stock for 2026, keeping an Outperform rating and a $211 target, driven by Microsoft backing and power visibility.
BofA Restarts Coverage on SoFi with Underperform Rating
Bank of America resumed coverage on SoFi Technologies with an Underperform rating, citing limited upside despite recent capital raises that support growth plans.
Deutsche Bank Turns Bullish on Shake Shack: Why SHAK Could Bounce in 2026
Deutsche Bank upgrades Shake Shack to Buy, citing strong growth, attractive valuation, and positive restaurant sector trends heading into 2026.